期刊
CURRENT OPINION IN LIPIDOLOGY
卷 19, 期 2, 页码 151-157出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MOL.0b013e3282f73893
关键词
epidemiology; genomics; phenotyping
资金
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077449] Funding Source: NIH RePORTER
- NHLBI NIH HHS [R01 HL-077449] Funding Source: Medline
Purpose of review Large-scale genomic studies establish genotype-phenotype associations, but they use phenotypes that represent current views of disease. There is an opportunity to enhance our understanding of genotype-phenotype associations by extending phenotypes into much greater detail ('deep phenotyping'). Recent findings We should engage in deep phenotyping for the following reasons. First, the current emphasis on clinical outcomes, although necessary for the advancement of clinical medicine, is not sufficient. Second, analytical and biological variance embedded in traditional phenotypes dilutes statistical power and strength of association. Finally, even relatively precise phenotypes may vary in terms of underlying pathophysiology across an individual's life history. Deep phenotyping focuses on the biological relevance of pathways and metabolic flux, increasing the 'granularity' of phenotypes. Summary Focus on medical phenotypes is critical, but long-term interests require additional studies that illuminate underlying biology. Deep phenotyping is less likely to yield dramatic changes in current medical practice but it offers an opportunity to gain scientific insight in an incremental manner and to make progress in redefining clinical outcomes with greater precision. It is expensive, and debate is needed to determine when and how it should be applied.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据